SIR -There is little question that the US health-care system requires reform. But it is debatable whether abdicating personal health-care decisions to an organization like the UK National Institute for Health and Clinical Excellence (NICE), as you recommend in your Editorials (Nature 461, 315-316 and 847; 2009) , is the best approach to reform.
NICE decides "which of the available medical options is most effective at treating any given condition". This is beyond reproach and deserving of the international accolades the organization has received. However, NICE also decides "which [medical option] is worth the money". To many Americans, this is objectionable. It is a subjective assessment intimately tied to the individual and shouldn't be in the hands of a committee.
There are myriad reform schemes being debated that still preserve an individual's control over health-care decisions. A poorly implemented private care scheme can always be reformed, but choosing government control means there is no turning back. According to these two indices, total research productivity and its impact both relate very strongly to the total funding received per university, but both relationships are significantly decelerating. (Details of these calculations are available from the author.) Expressed per dollar invested, research productivity and impact both decrease as funding per university increases. Bang for the research buck is better in smaller institutions.
Concentrating funding in large universities would probably increase their productivity, and perhaps their bragging rights. However, this would come at the price of reduced total research productivity summed over all Canadian universities. The same conclusion would probably apply to any system in which finite resources for research must be divided among a pool of contenders. And it is high time that those offering their organs for transplant -"after my death" are the words on NHS Organ Donor Register application forms -are clearly and fairly informed about the state they will be in if their offer is taken up.
David Currie
In the United Kingdom, 'death' is still being certified for that purpose on the basis of purely bedside tests of some brainstem functions. There has never been sound scientific support for this standard, and it was declared "clinically dangerous" in a report by the US President's Council on Bioethics last year (see go.nature. com/58y3DP).
As you assert, few things are as sensitive as death. Its certain diagnosis is surely of such importance that it should be addressed without concern for dependent interests. Lilavati was a mathematical treatise of the twelfth century, composed by the mathematician and astronomer Bhaskaracharya (1114-85) -also known as Bhaskara II -who was a teacher of repute and author of several other texts. The name Lilavati, which literally means 'playful', is a surprising title for an early scientific book. Some of the mathematical problems posed in the book are in verse form, and are addressed to a girl, the eponymous Lilavati.
David W. Evans
However, there is little real evidence concerning Lilavati's historicity. Tradition holds that she was Bhaskaracharya's daughter and that he wrote the treatise to console her after an accident that left her unable to marry. But this could be a later interpolation, as the idea was first mentioned in a Persian commentary. An alternative view has it that Lilavati was married at an inauspicious time and was widowed shortly afterwards.
Other sources have implied that Lilavati was Bhaskaracharya's wife, or even one of his students -raising the possibility that women in parts of the Indian subcontinent could have participated in higher education as early as eight centuries ago.
However, given that Bhaskara was a poet and pedagogue, it is also possible that he chose to address his mathematical problems to a doe-eyed girl simply as a whimsical and charming literary device.
